| Filed On | Filing |
|---|---|
| 15 Jun 2021 |
8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
VIRIDIAN THERAPEUTICS, INC., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify: |
| 01 Oct 2020 |
8-K/A: Departure/Election of Directors or Officers; Compensation
You are receiving this letter because you are a participant in the annual bonus program (the “Bonus Program”) of Miragen Therapeutics, Inc. (the “Company”). The Company is pleased to inform you that in gratitude for your efforts on behal... |
| 27 Mar 2018 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On March 21, 2018, Arlene M. Morris was named as a member of the nominating and corporate governance committee of the Company’s board of directors. |
| 31 Mar 2017 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying consolidated balance sheets of Miragen Therapeutics, Inc. and subsidiary as of December 31, 2016 and 2015, and the related consolidated statements of operations, preferred stock and stockholders’ deficit,... |
Loading...